FTC: ‘Pharma bro’ Shkreli violated lifetime industry ban, should be held in contempt

descriptions off, selected

captions settings, opens captions settings dialog

captions off, selected

This is a modal window.

Beginning of dialog window. Escape will cancel and close the window.

End of dialog window.

Trending on The Hill - October 13, 2026

Trending on The Hill - October 13, 2026

The Federal Trade Commission (FTC) and a coalition of seven states asked a federal court on Tuesday to punish Martin Shkreli for “flagrantly and repeatedly” violating a lifetime ban from being involved in the pharmaceutical industry. 

In a court filing in the U.S. District Court for the Southern District of New York, the FTC said Shkreli has traded in at least 60 pharmaceutical stocks since being released from prison in 2022. He’s also been broadcasting his opinions about the business and management of the companies through livestreaming and posting on numerous social media platforms. 

The coalition asked a federal judge to hold Shkreli in........

© The Hill